Maria Rita Teixeira Dutra
Overview
Explore the profile of Maria Rita Teixeira Dutra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McClure M, de Rezende I, Pereira L, Dutra M, Fradico J, Macedo R, et al.
Front Med (Lausanne)
. 2025 Feb;
12:1505005.
PMID: 39931562
Objective: To characterize the clinical manifestations of yellow fever disease and identify risk factors for mortality. Methods: A retrospective study was conducted in the referral center for infectious diseases (Hospital...
2.
Correa-Castro G, Silva-Freitas M, de Paula L, Pereira L, Dutra M, Albuquerque H, et al.
Sci Rep
. 2024 Apr;
14(1):9870.
PMID: 38684845
Visceral leishmaniasis (VL) is an infectious disease caused by Leishmania infantum. Clinically, VL evolves with systemic impairment, immunosuppression and hyperactivation with hypergammaglobulinemia. Although renal involvement has been recognized, a dearth...
3.
Fradico J, Campi-Azevedo A, Speziali E, Antonelli L, Peruhype-Magalhaes V, de Rezende I, et al.
Clin Immunol
. 2023 Apr;
251:109321.
PMID: 37019421
This study described a soluble mediator storm in acute Yellow Fever/YF infection along the kinetics timeline towards convalescent disease. The analyses of the YF Viral RNAnemia, chemokines, cytokines, and growth...
4.
Gouveia-Eufrasio L, Ribeiro N, Santos J, da Costa M, Peres Emidio E, de Freitas G, et al.
Contemp Clin Trials Commun
. 2021 May;
22:100745.
PMID: 33997457
Background: Cryptococcosis affects more than 220,000 patients/year, with high mortality even when the standard treatment [amphotericin B (AMB), 5-flucytosin (5-FC) and fluconazole] is used. AMB presents high toxicity and 5-FC...
5.
Kuschnir R, Pereira L, Dutra M, de Paula L, Silva-Freitas M, Correa-Castro G, et al.
BMC Infect Dis
. 2021 Apr;
21(1):369.
PMID: 33874901
Background: Visceral leishmaniasis (VL) is severe and potentially fatal. Brazil is one of the countries with the greatest endemicity for the disease in the world. The reduction of CD4 T...
6.
de Rezende I, Augusto Alves P, Arruda M, Goncalves A, Oliveira G, Pereira L, et al.
Vaccines (Basel)
. 2019 Dec;
7(4).
PMID: 31817103
The yellow fever (YF) vaccine consists of an attenuated virus, and despite its relative safety, some adverse events following YF vaccination have been described. At the end of 2016, Brazil...
7.
de Rezende I, Sacchetto L, de Mello E, Augusto Alves P, de Melo Iani F, Adelino T, et al.
PLoS Negl Trop Dis
. 2018 Jun;
12(6):e0006538.
PMID: 29864115
Background: Yellow fever (YF) is endemic in the Brazilian Amazon Basin, and sporadic outbreaks take place outside the endemic area in Brazil. Since 2016, YF epidemics have been occurring in...
8.
Dutra M, Campos L, Crosland Guimaraes M
Braz J Infect Dis
. 2013 Aug;
18(1):13-20.
PMID: 23933407
Sexually transmitted diseases are still highly prevalent worldwide and represent an important public health problem. Psychiatric patients are at increased risk of sexually transmitted diseases but there are scarce published...